Logo
Dwayne Jhonson @go_679b7563d09da
GLP-1 Market Research is Expecting to Accrue Strong Growth in Forecast to 2035

The global GLP-1 receptor agonist market is poised for significant growth, expanding from an estimated USD 49.3 billion in 2024 to USD 157.5 billion by 2035, reflecting a compound annual growth rate (CAGR) of 11.1% over this period. This robust expansion is driven by increasing demand for treatments targeting type 2 diabetes and obesity, alongside emerging applications in other health conditions.

Market Growth Drivers

GLP-1 drugs primarily manage blood glucose levels in individuals with type 2 diabetes and have shown efficacy in treating obesity and related cardiovascular diseases. The rising prevalence of obesity—affecting 42.4% of U.S. adults—and diabetes, with nearly 530 million adults affected globally (98% with type 2 diabetes), underpins the growing market demand. The World Health Organization reports that obesity causes approximately 4 million deaths annually, while diabetes remains a leading cause of mortality worldwide.

URL: https://www.rootsanalysis....
01:11 PM - May 15, 2025 (UTC)

No replys yet!

It seems that this publication does not yet have any comments. In order to respond to this publication from Dwayne Jhonson, click on at the bottom under it